Company news
Medipharm Labs Corp. (TSX:LABS) news
Every Medipharm Labs Corp. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases & updates
MediPharm Labs Reports Positive Q2 2026 Net Income and Second Consecutive Quarter of Positive Adjusted EBITDA
August 13, 2026
MediPharm Labs Sets Date to Report Second Quarter 2026 Financial Results
August 10, 2026
MediPharm Labs Announces Positive Phase II LiBBY Trial Results Demonstrating Significant Reduction in Agitation Associated With Advanced ...
July 14, 2026
MediPharm Labs Announces Voting Results from the 2026 Annual and Special Meeting of Shareholders
June 17, 2026
MediPharm Labs Reminds Shareholders of Upcoming Annual and Special Meeting
May 28, 2026
MediPharm Labs Reports First Quarter 2026 Results Achieving Positive Adjusted EBITDA
May 13, 2026
MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results
May 7, 2026
MediPharm Labs Positioned to Serve Growing U.S. Pharmaceutical and Clinical Research Demand Following Cannabis Rescheduling
April 27, 2026
MediPharm Labs Reports Full Year & Fourth Quarter 2025 Results with Over 40% Annual Growth in International Medical Revenue
March 30, 2026
MediPharm Labs Sets Date to Report Full Year and Fourth Quarter 2025 Financial Results
March 25, 2026
MediPharm Labs Announces CEO Transition: David Pidduck to Step Down; CFO Greg Hunter Appointed Interim CEO
January 19, 2026
MediPharm Labs to Enter New Market with Costa Rica Supply Agreement
January 13, 2026
Historic U.S. Cannabis Rescheduling Unlocks Potential Growth Opportunities for MediPharm Labs, Backed by the Company's Suite of Licenses ...
December 19, 2025
MediPharm Labs Announces Board of Directors Changes: Shelley Potts Steps Down, Michael Bumby Returns
December 10, 2025
MediPharm Labs Completes First Shipment to France
December 4, 2025
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
November 14, 2025
MediPharm Advances Global Reach in Q3 2025 with Double-Digit Revenue Growth and Strong International Medical Cannabis Gains
November 13, 2025
MediPharm Labs Sets Date to Report Third Quarter 2025 Financial Results
November 10, 2025
/U P D A T E -- MediPharm Labs Corp./
November 7, 2025
MediPharm Labs Files Proxy Materials, Issues Chair's Letter to Shareholders
November 7, 2025
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
August 14, 2025
MediPharm Labs Positioned for Unique Opportunities on Possible Rescheduling of Cannabis in the United States
August 13, 2025
MediPharm Labs Sets Date to Report Second Quarter 2025 Financial Results
August 11, 2025
MediPharm Labs Expands Leading CBN Oil Portfolio with The Launch of New Nighttime Inhaler
July 24, 2025
MediPharm Announces Voting Results from the 2025 Annual and Special Meeting of Shareholders
June 17, 2025
MediPharm Cautions Shareholders To Await Final Results of Annual and Special Meeting
June 16, 2025
Apollo Capital Wins Proxy Contest at MediPharm Labs
June 16, 2025
Leading Independent Proxy Advisor Glass Lewis Recommends Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees
June 13, 2025
MediPharm Reminds Shareholders to Vote in Advance of June 13 Deadline
June 11, 2025
MediPharm Announces Complete Dismissal of Dissident Court Proceeding Related to Annual and Special Meeting
June 11, 2025
Apollo Capital Releases Investor Presentation Highlighting Plan to Make MediPharm Labs the World's Leading International Medical Cannabis...
June 11, 2025
MediPharm Labs' Founder-CEO Pat McCutcheon Throws his Support behind Apollo Capital as Dissident
June 9, 2025
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
June 5, 2025
MediPharm Labs Closes $4.5 Million Sale of Hope, BC Facility and Announces Plans to Expand EU GMP Cultivation Capacity at Napanee Facility
June 5, 2025
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; REJECTS Apol...
June 2, 2025
Leading Independent Proxy Advisor ISS Recommends that Shareholders Vote the GREEN proxy FOR ALL MediPharm Director Nominees; RE...
June 2, 2025
MediPharm Labs Refuses to Answer Direct Questions Regarding Credible Securities Fraud Allegations Says Apollo Capital
May 30, 2025
MediPharm Labs Responds to Fabricated Allegations from Dissident Shareholder
May 29, 2025
Alleged Securities Fraud at MediPharm Labs Says Apollo Capital
May 29, 2025
MediPharm Labs Board Issues Letter to Shareholders in Response to Inadequate Dissident Plan
May 28, 2025
Apollo Capital Calls Out MediPharm Chairman Chris Taves (Managing Director, BMO Capital Markets) for Failure to Properly Communicate to S...
May 27, 2025
MediPharm Labs Begins Production of First Order for International Expansion of Novel Cannabis Metered Dose Portfolio in the EU and United...
May 26, 2025
MediPharm Labs Cautions Shareholders about Dissident Nominees’ Governance Failures at Check-Cap Ltd.
May 23, 2025
MediPharm Labs Cautions Shareholders about Dissident Nominees' Governance Failures at Check-Cap Ltd.
May 23, 2025
Apollo Capital Comments on MediPharm Labs' Failure to Respond to Reasonable Offer to Ensure Fair, Lawful and Transparent 2025 Annual Meeting
May 23, 2025
MediPharm Achieves Key Milestone Toward $4.5 Million Cash Sale of Hope Facility, On Track to Close in June
May 22, 2025
Apollo Capital Issues a With Prejudice Offer to MediPharm Labs and Its Board of Directors to Ensure Shareholder Rights Are Protected at t...
May 21, 2025
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
May 21, 2025
MediPharm Labs Alerts Shareholders to Allegations Made Against Regan McGee in Multiple Litigation Filings
May 21, 2025
COMPLETE Board Change is Urgently Needed at MediPharm Labs! Apollo Technology Capital Corporation Files Amended and Restated Proxy Circul...
May 20, 2025